Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Post by rudeawakeningon Dec 01, 2020 2:45pm
465 Views
Post# 32011132

Don't Sleep on CANA

Don't Sleep on CANACannamerica (CANA) had some nice news this morning. This stock is ridiculously undervalued at a $1.3M market cap imo. Sure their financials suck but that's the same story for hundreds of other public cannabis companies. This was shorted down to a cent!!! 

TD sold 505 shares the other day on the ATS and you know what that indicates? They're short. You can see them driving their bid up to cover their position. They're going to have to slap the ask cause the trend has changed here. 

I have heard other investors speak to CEO recently and he mentioned that they're doing well despite the poor revenues this year (coronavirus caused production issues). But they've been expanding into 250+ dispensaries, and their product is a "high dosage" edible and extracts that are of high demand (and profit margin).

Imo, this is cheap at these levels and we could see a trend back to .10 pretty quickly on FOMO of a great opportunity. I'd imagine the big firms who invested in the PP at  .60 & .30 have hopes to come out on top one day. Do your DD as always.
<< Previous
Bullboard Posts
Next >>